Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update on Acinetobacter baumannii].

Marie-Laure Joly-Guillou1

  • 1Hôpital Louis Mourier 178, rue des Renouilliers 92701 Colombes. marie-laure.joly-guillou@lmr.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|December 25, 2002
PubMed
Summary

The growing resistance of Acinetobacter baumannii to imipenem is a significant concern due to diverse resistance enzymes and widespread infections. Early appropriate antibiotic therapy is crucial for improving outcomes in Acinetobacter infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Critical care testing: SFBC recommendations in 2018].

Annales de biologie clinique·2018
Same author

Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia.

Future microbiology·2017
Same author

Impact of faecal microbiota transplantation on mouse digestive colonization with two extensively resistant bacteria.

The Journal of infection·2017
Same author

First case of OXA-24-producing Acinetobacter baumannii in cattle from Reunion Island, France.

International journal of antimicrobial agents·2016
Same author

Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2016
Same author

Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2016

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Acinetobacter baumannii infections are increasingly difficult to treat due to rising imipenem resistance.
  • Diverse enzymes contribute to resistance, and epidemic spread poses challenges.
  • Broad-spectrum beta-lactamases, though rare in Acinetobacter, have been identified.

Purpose of the Study:

  • To identify risk factors for mortality in Acinetobacter infections.
  • To understand the implications of slime production on treatment.
  • To outline strategies for combating Acinetobacter infections.

Main Methods:

  • A survey of 28 Spanish hospitals identified mortality risk factors.
  • Analysis of treatment timing based on slime production.
  • Epidemiological data on resistance patterns and enzyme diversity.

Main Results:

  • Hospitalization in intensive care units and inappropriate antibiotic therapy are key mortality risk factors.
  • Early antibiotic administration is recommended for slime-producing strains.
  • A broad-spectrum beta-lactamase was identified in a strain causing a urinary infection outbreak.

Conclusions:

  • Combating Acinetobacter requires breaking epidemic chains and implementing judicious antibiotic use policies.
  • Understanding resistance mechanisms and risk factors is vital for effective treatment.
  • Tailoring antibiotic strategies based on bacterial characteristics like slime production is important.

Related Experiment Videos